Inger Nilsson

Astrocytes: biology and pathology

Neurofilament light chain as a biomarker in neurological disorders

S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment

Nrf2-Keap1 signaling in oxidative and reductive stress

Reasons and Determinants for Not Receiving Treatment for Common Mental Disorders

Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies

NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches

Biological and methodological features of the measurement of S100B, a putative marker of brain injury

Plasma glial fibrillary acidic protein levels in children with sickle cell disease

Neurochemical Aftermath of Amateur Boxing

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

The Role of Markers of Inflammation in Traumatic Brain Injury

Neuroinflammation: the devil is in the details

Functions of S100 Proteins

Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury

Guidelines for the Primary Prevention of Stroke

Part 8: Post–Cardiac Arrest Care

IKK2/NF‐κB signaling protects neurons after traumatic brain injury

Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome

A nurse‐led rheumatology clinic’s impact on empowering patients with rheumatoid arthritis: A qualitative study

Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury